Inside WeightWatchers’ bold pivot to dominate the Ozempic era
WeightWatchers’ bold gamble: CEO Sistani fuses AI, GLP-1 drugs, and 60 years of trust into a revolutionary health tech platform to conquer the $377B weight loss market.
WeightWatchers’ bold gamble: CEO Sistani fuses AI, GLP-1 drugs, and 60 years of trust into a revolutionary health tech platform to conquer the $377B weight loss market.
Hourly workers at Jenny Craig could have already worked their last shift, according to an internal message to employees.